Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-574-5 | CAS number: 122-78-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
Oral (similar to OECD 401), rat: LD50 calculated = 1550 mg/kg bw
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Remarks:
- Limited documentation. No information on analytical purity of test substance given.
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- yes
- Remarks:
- Limited documentation. No information on analytical purity of test substance given.
- GLP compliance:
- not specified
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rat
- Strain:
- not specified
- Sex:
- not specified
- Route of administration:
- oral: unspecified
- Vehicle:
- not specified
- Doses:
- 840, 2050, 4000, 5000 and 6250 mg/kg bw
- No. of animals per sex per dose:
- 10 in total
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, gross pathology - Key result
- Sex:
- not specified
- Dose descriptor:
- LD50
- Effect level:
- 1 550 mg/kg bw
- Based on:
- test mat.
- Mortality:
- 840 mg/kg bw: 3/10 animals died
2050 mg/kg bw: 5/10 animals died
4000 mg/kg bw: 10/10 animals died
5000 mg/kg bw: 6/10 animals died
6250 mg/kg bw: 8/10 animals died - Clinical signs:
- other: 840 mg/kg bw: No clinical signs were observed within study period. 2050 mg/kg bw: lethargy and flaccidity 4000 mg/kg bw: lethargy, ptosis, piloerection and convulsions in one animal 5000 mg/kg bw: lethargy, ptosis, piloerection 6250 mg/kg bw: lethargy,
- Gross pathology:
- Gross pathology of animals revealed red / yellow stomach and intestine, yellow exudate of nose and mouth in one animal, yellow coloured portions of interior abdominal wall, blood in lumen of intestine, red small intestine, blood in bladder, dark liver, kidney and lungs and signs of cannibalization.
- Interpretation of results:
- other: Acute Tox. 4 according to Regulation (EC) No 1272/2008
- Conclusions:
- In this acute oral toxicity study a LD50 value of 1550 mg/kg bw was derived in rats.
Reference
Table 1. Results of the acute oral toxicity study.
Dose level (mg/kg bw) |
Mortalities |
|
n |
840 |
3/10 |
2050 |
5/10 |
4000 |
10/10 |
5000 |
6/10 |
6250 |
8/10 |
Table 2. Clinical signs found in necropsy.
Clinical signs |
No of rats with clinical sign at respective dose [mg/kg bw] |
||||
840 |
2050 |
4000 |
5000 |
6250 |
|
Red stomach and intestine |
1 |
0 |
1 |
2 |
0 |
Yellow stomach and intestine |
0 |
4 |
5 |
4 |
7 |
Dark liver |
0 |
3 |
2 |
3 |
7 |
Yellow exudate of nose and mouth |
1 |
4 |
8 |
2 |
7 |
Yellow portions of interior abdominal wall |
0 |
1 |
3 |
1 |
1 |
Blood in lumen of intestine |
0 |
0 |
1 |
1 |
1 |
Red small intestine |
0 |
2 |
3 |
0 |
6 |
Blood in bladder |
0 |
1 |
0 |
0 |
1 |
Dark kidneys |
0 |
0 |
0 |
0 |
5 |
Dark lungs |
0 |
2 |
3 |
0 |
1 |
Signs of cannibalization |
1 |
0 |
0 |
0 |
0 |
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 1 550 mg/kg bw
- Quality of whole database:
- The available information comprises an adequate and reliable study (Klimisch score 2), and is thus sufficient to fulfil the standard information requirements set out in Annex VII, 8.5, of Regulation (EC) No 1907/2006.
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Oral
The acute oral toxicity of the test substance was assessed in a study similar to OECD Guideline 401 (1977). The test substance was administred orally in doses of 840, 2050, 4000, 5000 and 6250 mg/kg bw to 10 rats per group. In the 840 mg/kg bw dose group one animal died within 24 h, two additional animals each on Day 5 and 6. In the 2050 and 4000 mg/kg bw dose groups five animals died within 24 h. In the 4000 mg/kg bw dose group seven animals died within 24 h, two additional animals on Day 2 and one on Day 6. In the dose groups of 5000 and 6250 mg/kg bw five and seven animals were found dead within 24 h and one additional animal on Day 2, respectively. Animals were found lethargic, flaccid and showed ptosis, piloerection and convulsion. At gross pathology reddening or yellowish colour of the stomach, abdominal wall and intestines, dark liver, kidneys and lungs, exudate of mouth and nose, blood in lumen of intestine and bladder and signs of cannibalism were found. The LD50 for rats was calculated to be 1550 mg/kg bw.
Justification for classification or non-classification
The available data on acute oral toxicity of the test substance meet the criteria for Acute Tox. 4 (H302) according to Regulation (EC) 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.